Envision Pharma Group: acquisition of Two Labs
Envision Pharma Group has acquired Two Labs, a company that provides a range of integrated commercial solutions to pharma and biotech firms. The move is designed to bring together complementary clients, services and technologies, and extend Envision’s capabilities in the product pre-launch arena.
Envision CEO David Thompson said, “This exciting combination of Envision and Two Labs creates a compelling and unrivaled proposition in launch excellence partnership globally and in the US. We look forward to sharing our joint expertise and leveraging our complementary services across medical affairs and product launch planning to support our clients in their goal of bringing new medicines to market effectively and compliantly, to improve patient outcomes.”
